MedTrace Logo

Treatment of Hypertension With Adalat® in Combination With Other Drugs

NCT01118286 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4497

Last updated 2012-06-27

No results posted yet for this study

Summary

To investigate the therapeutic effectiveness of long acting nifedipine containing combination therapy in the treatment of hypertensive patients.

Conditions

Interventions

DRUG

Nifedipine (Adalat, BAYA1040)

Previously untreated hypertensive adult patients starting with combination therapy containing nifedipine or insufficiently controlled hypertensive patients receiving nifedipine as an add-on to existing non-CCB containing antihypertensive therapy. The decision of including the patient as well as decision on dosage and duration is taken by the investigator.

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Completion
2011-09-30

Countries

  • Bahrain
  • Egypt
  • Jordan
  • Lebanon
  • Morocco
  • Oman
  • Pakistan
  • Qatar
  • Russia
  • Saudi Arabia
  • United Arab Emirates

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01118286 on ClinicalTrials.gov